Company Filing History:
Years Active: 2005-2008
Title: Innovations of Raymond Ferri
Introduction
Raymond Ferri is a notable inventor based in Providence, RI (US). He has made significant contributions to the field of therapeutics, particularly in relation to biglycan and its associated disorders. With a total of 2 patents, Ferri's work is paving the way for advancements in medical treatments.
Latest Patents
Ferri's latest patents focus on "Biglycan and related therapeutics and methods of use." This invention provides compositions and methods for treating, preventing, and diagnosing diseases or conditions associated with an abnormal level or activity of biglycan. It addresses disorders linked to an unstable cytoplasmic membrane, which may arise from an unstable dystrophin-associated protein complex (DAPC). Additionally, it tackles disorders related to abnormal synapses or neuromuscular junctions, including those caused by abnormal MuSK activation or acetylcholine receptor (AChR) aggregation. Examples of diseases targeted by this invention include muscular dystrophies, such as Duchenne's Muscular Dystrophy and Becker's Muscular Dystrophy, as well as various neuromuscular and neurological disorders.
Career Highlights
Raymond Ferri is affiliated with Brown University, where he continues to engage in innovative research and development. His work is instrumental in advancing therapeutic options for patients suffering from debilitating conditions.
Collaborations
Ferri collaborates with esteemed colleagues, including Justin R. Fallon and Beth A. McKechnie. Their combined expertise enhances the research and development efforts in the field of therapeutics.
Conclusion
Raymond Ferri's contributions to the field of therapeutics, particularly through his patents related to biglycan, demonstrate his commitment to improving medical treatments. His work at Brown University and collaborations with fellow researchers further solidify his impact in the realm of innovation.